Literature DB >> 25245905

Serum albumin as a biomarker of capillary leak in scuba divers with neurological decompression sickness.

Emmanuel Gempp1, Sebastien De Maistre, Pierre Louge.   

Abstract

BACKGROUND: Prior reports have shown that decompression sickness (DCS) in scuba divers is accompanied by vascular endothelium damage attributed to gas emboli formation, resulting in capillary leak with hemoconcentration. The significance of serum albumin as a biomarker of vascular permeability in this condition has been insufficiently investigated. We studied whether there was a relationship between low serum albumin values on admission and the occurrence of neurological DCS.
METHODS: Demographic, diving, and laboratory data of 52 randomly selected DCS divers were compared with those of 52 asymptomatic divers referred for inadequate decompression. The diagnostic performance of serum albumin in predicting neurological DCS was assessed.
RESULTS: Both groups did not differ from the variables examined. Serum albumin was significantly lower in injured divers than in controls (38.7 ± 3 g · L(-1) vs. 41 ± 2.9 g · L(-1)). At a cut-off value of 35.2 g · L(-1), we found a specificity of 98% (95% CI 90-100) and a sensitivity of 16% (95% CI 7-28) for the prediction of neurological DCS development.
CONCLUSION: Our findings suggest that hypoalbuminemia at initial presentation, albeit rare, accurately predicts the occurrence of neurological DCS in scuba divers. The prognostic value of this biomarker and the potential beneficial role of albumin infusion in more severe cases remain to be investigated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25245905     DOI: 10.3357/ASEM.4069.2014

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  4 in total

1.  Case report: Physiological changes due to a rapid ascent from 55 metres underwater.

Authors:  Michele Homsy; Catherine Bounds; Mark Glover; Benjamin Castledine; Timothy Martindale
Journal:  J Intensive Care Soc       Date:  2019-12-13

2.  Thirty-five Day Fluoxetine Treatment Limits Sensory-Motor Deficit and Biochemical Disorders in a Rat Model of Decompression Sickness.

Authors:  Caroline Cosnard; Sébastien De Maistre; Jacques H Abraini; Laurent Chazalviel; Jean-Eric Blatteau; Jean-Jacques Risso; Nicolas Vallée
Journal:  Front Physiol       Date:  2017-09-05       Impact factor: 4.566

3.  Decompression illness with hypovolemic shock and neurological failure symptoms after two risky dives: a case report.

Authors:  Sebastian Klapa; Johannes Meyne; Wataru Kähler; Frauke Tillmans; Henning Werr; Andreas Binder; Andreas Koch
Journal:  Physiol Rep       Date:  2017-03

4.  Tirofiban, a Glycoprotein IIb/IIIa Antagonist, Has a Protective Effect on Decompression Sickness in Rats: Is the Crosstalk Between Platelet and Leukocytes Essential?

Authors:  Kate Lambrechts; Sébastien de Maistre; Jacques H Abraini; Jean-Eric Blatteau; Jean-Jacques Risso; Nicolas Vallée
Journal:  Front Physiol       Date:  2018-07-11       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.